Pfizer CEO McKinnell’s Successor Is General Counsel Kindler
This article was originally published in The Pink Sheet Daily
Executive Summary
McKinnell will remain as Pfizer's chairman until February 2007.
You may also be interested in...
Cost-Cutting Initiative Will Create “A More Agile” Pfizer
Pfizer announces cost cuts to reduce 2007 operating expenses below 2006 level during the firm’s third quarter earnings call.
Cost-Cutting Initiative Will Create “A More Agile” Pfizer
Pfizer announces cost cuts to reduce 2007 operating expenses below 2006 level during the firm’s third quarter earnings call.
Pfizer Revs Acquisition Engine; New Management Has $17 Bil. To Spend On Deals
Pfizer signs licensing agreement with Quark Biotech to develop a novel human gene for treatment of wet age-related macular degeneration.